Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHalma Regulatory News (HLMA)

Share Price Information for Halma (HLMA)

Share Price is delayed by 15 minutes
Get Live Data
4,722.00    58.00 (1.24%)
Bid:
4,712.00
Ask:
4,716.00
Spread: 4.00 (0.085%)
Market Cap: £17.84b
HLMA Live PriceLast checked at - London Stock Exchange

Intraday Halma Share Chart

Acquisition

17 Dec 2010 07:00

RNS Number : 1449Y
Halma PLC
17 December 2010
 



Halma p.l.c. ('Halma')

 

ACQUISITION OF ACCUDYNAMICS, INC

 

 

Halma, the leading safety, health and sensor technology group, today announces the acquisition of Accudynamics, Inc. ('ADI') on 16 December 2010 for an initial cash consideration of $24.0 million (£15.2 million).

 

ADI is a privately owned business based in Lakeville, Massachusetts, USA and manufactures components primarily for the medical diagnostic system and device markets. Their bespoke products include pumps, fluid handling components and integrated electromechanical assemblies which transport fluids inside their customers' products. ADI will join Halma's Health and Analysis sector within the Fluid Technology group of businesses.

 

Unaudited adjusted accounts for the financial year ended June 2010 show operating profit of $3.7 million (£2.3 million). The initial cash consideration is adjustable $1 for $1 if the completion accounts demonstrate net tangible assets above or below $3.6m (£2.3m). A further $7 million (£4.4 million) is payable based on earnings growth for the period 1 July 2010 to 31 March 2011. The acquisition, which is immediately earnings enhancing, has been funded from Halma's existing cash and debt facilities.

 

Andrew Williams, Halma's Chief Executive, commented:

"ADI is a logical extension of our Fluid Technology sub-sector, enabling us to offer OEM customers integrated sub-assemblies incorporating components from different Halma companies. Following our recent acquisition of Alicat Scientific in November, we have a strong offering for customers requiring precision fluid control in the scientific and medical diagnostic market segments."

 

 

For further information please contact:

 

Halma p.l.c.

Andrew Williams, Chief Executive

Kevin Thompson, Finance Director

 

+44 (0)1494 721111

MHP Communications

Rachel Hirst/Andrew Jaques

+44 (0)20 3128 8100

 

Notes

1.

A copy of this announcement, together with other information about Halma, may be viewed on its website: www.halma.com.

2.

This statement is not intended to constitute a profit forecast for the current financial period or for any future period. In addition, this statement should not be taken to mean that the earnings per share of Halma will necessarily match or exceed the historic reported earnings per share of Halma.

3.

Exchange rate used: $1.58/£1.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQTFBRTMBABBMM
Date   Source Headline
15th Oct 20211:06 pmRNSDirector/PDMR Shareholding
4th Oct 20212:12 pmRNSDirector/PDMR Shareholding
23rd Sep 20211:01 pmRNSDirector/PDMR Shareholding
22nd Sep 20217:00 amRNSTrading update
9th Sep 202110:22 amRNSDirector Declaration
9th Aug 20217:00 amRNSM&A Update
26th Jul 202111:01 amRNSDirector/PDMR Shareholding
22nd Jul 20213:00 pmRNSResult of AGM
5th Jul 20214:05 pmRNSDirector/PDMR Shareholding
30th Jun 20211:50 pmRNSDirector/PDMR Shareholding
23rd Jun 20214:47 pmRNSAnnual Financial Report
10th Jun 20217:01 amRNSUnaudited restated segmental information
10th Jun 20217:00 amRNSFull Year Results 2021
27th Apr 20217:00 amRNSAcquisition
26th Mar 20217:00 amRNSAppointment of independent non-executive Director
24th Mar 20217:00 amRNSTrading update
23rd Feb 20217:54 amRNSDirector Declaration
10th Feb 20214:52 pmRNSDirector/PDMR Shareholding
9th Feb 20217:00 amRNSDirectorate Change
21st Dec 20202:00 pmRNSAcquisition
18th Dec 20207:00 amRNSDisposal
4th Dec 20207:04 amRNSDirector Declaration
2nd Dec 20204:08 pmRNSDirector/PDMR Shareholding
25th Nov 20203:20 pmRNSDirector/PDMR Shareholding
19th Nov 20207:00 amRNSHALF YEAR RESULTS 2020/21
5th Oct 20201:12 pmRNSDirector/PDMR Shareholding
23rd Sep 20207:05 amRNSDirector Declaration
23rd Sep 20207:00 amRNSChair retirement
23rd Sep 20207:00 amRNSTrading update
4th Sep 20204:57 pmRNSResult of AGM
31st Jul 20204:06 pmRNSDirector/PDMR Shareholding
24th Jul 20205:02 pmRNSAnnual Financial Report
17th Jul 20209:32 amRNSDirector/PDMR Shareholding
14th Jul 20207:00 amRNSFinal Results
15th May 20201:29 pmRNSElectronic Communications with Shareholders
27th Apr 202012:46 pmRNSDisclosure of Rights Attached to Equity Shares
21st Apr 20207:00 amRNSCOVID-19 Update
2nd Apr 20207:05 amRNSExecutive Board changes
19th Mar 20207:00 amRNSTrading Statement
5th Mar 20209:00 amRNSInvestor Event
24th Feb 202011:31 amRNSHolding(s) in Company
21st Feb 20207:00 amRNSAcquisition
5th Feb 20207:00 amRNSAcquisition
27th Jan 20207:00 amRNSAcquisition
22nd Jan 202012:58 pmRNSChange of Remuneration Committee Chair
29th Nov 20191:27 pmRNSDirector/PDMR Shareholding
25th Nov 20195:10 pmRNSDirector/PDMR Shareholding
19th Nov 201911:45 amRNSDividend Declaration
19th Nov 20197:00 amRNSHalf-year Report
2nd Oct 20195:02 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.